Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4548641000168116 | Lyzalon (pregabalin 150 mg) capsule, 500 capsules, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4548651000168119 | Lyzalon 150 mg capsule, 500, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lyzalon 150 mg capsule, 500, bottle | Is a | Lyzalon 150 mg capsule, 500 | true | Inferred relationship | Some | ||
| Lyzalon 150 mg capsule, 500, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lyzalon 150 mg capsule, 500, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Lyzalon 150 mg capsule, 500, bottle | has TP | Lyzalon | true | Inferred relationship | Some | ||
| Lyzalon 150 mg capsule, 500, bottle | has TPUU | Lyzalon (pregabalin 150 mg) capsule (trade product unit of use) | true | Inferred relationship | Some | 60434384 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Containered trade product pack reference set
FHIR